Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Singaporean (SGX) Healthcare Sector Analysis

UpdatedJan 24, 2025
DataAggregated Company Financials
Companies29
  • 7D1.3%
  • 3M1.4%
  • 1Y5.1%
  • YTD0.008%

Thomson Medical Group is up 4.3%, leading the way for the Healthcare industry, which has gained 2.1%. This means that the industry has gained 5.0% over the past year. As for the next few years, earnings are expected to grow by 11% per annum.

Sector Valuation and Performance

Has the Singaporean Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 24 Jan 2025S$8.8bS$3.0bS$350.6m16.5x25x2.9x
Sun, 22 Dec 2024S$8.7bS$3.0bS$349.4m16.3x24.9x2.9x
Tue, 19 Nov 2024S$8.8bS$3.0bS$349.5m16.8x25.1x2.9x
Thu, 17 Oct 2024S$8.6bS$2.9bS$360.1m16.1x23.9x2.9x
Sat, 14 Sep 2024S$8.5bS$3.0bS$362.8m16.3x23.5x2.9x
Mon, 12 Aug 2024S$8.3bS$2.9bS$336.4m17.7x24.7x2.9x
Wed, 10 Jul 2024S$8.7bS$2.9bS$364.5m16.9x23.9x3x
Fri, 07 Jun 2024S$8.6bS$2.9bS$364.6m16.8x23.6x3x
Sun, 05 May 2024S$8.3bS$2.9bS$357.8m15.9x23.3x2.9x
Tue, 02 Apr 2024S$8.6bS$2.9bS$411.9m14x20.8x2.9x
Thu, 29 Feb 2024S$8.5bS$2.9bS$411.3m15.1x20.7x2.9x
Sat, 27 Jan 2024S$9.0bS$3.2bS$441.6m15x20.5x2.8x
Mon, 25 Dec 2023S$9.2bS$3.2bS$441.3m15.3x20.9x2.9x
Wed, 22 Nov 2023S$12.1bS$4.4bS$581.7m15.8x20.9x2.8x
Fri, 20 Oct 2023S$11.9bS$4.4bS$595.1m15.8x20x2.7x
Sun, 17 Sep 2023S$12.6bS$4.4bS$599.0m16.2x21x2.9x
Tue, 15 Aug 2023S$13.3bS$4.4bS$652.3m16.1x20.4x3x
Thu, 13 Jul 2023S$13.4bS$4.5bS$647.3m15.5x20.7x3x
Sat, 10 Jun 2023S$13.9bS$4.5bS$652.2m15.1x21.3x3.1x
Mon, 08 May 2023S$14.5bS$4.6bS$675.3m16x21.5x3.2x
Wed, 05 Apr 2023S$14.1bS$4.6bS$634.2m14.7x22.2x3.1x
Fri, 03 Mar 2023S$13.2bS$4.4bS$634.6m16.1x20.8x3x
Sun, 29 Jan 2023S$13.5bS$4.4bS$680.2m15.9x19.8x3x
Tue, 27 Dec 2022S$13.0bS$4.4bS$677.5m15.6x19.1x2.9x
Thu, 24 Nov 2022S$13.0bS$4.4bS$673.3m15.7x19.3x3x
Sat, 22 Oct 2022S$12.0bS$4.5bS$726.7m14.2x16.5x2.7x
Mon, 19 Sep 2022S$13.1bS$4.5bS$737.0m15.5x17.8x2.9x
Wed, 17 Aug 2022S$13.1bS$4.5bS$787.4m16x16.6x2.9x
Fri, 15 Jul 2022S$12.9bS$4.7bS$980.2m15.2x13.1x2.7x
Sun, 12 Jun 2022S$12.9bS$4.7bS$978.9m14.6x13.1x2.7x
Tue, 10 May 2022S$12.8bS$4.9bS$1.1b14x11.6x2.6x
Thu, 07 Apr 2022S$14.2bS$4.9bS$1.1b14.8x12.7x2.9x
Sat, 05 Mar 2022S$13.9bS$5.0bS$1.1b14.3x12.4x2.8x
Mon, 31 Jan 2022S$13.9bS$5.1bS$1.2b14.4x11.6x2.7x
Price to Earnings Ratio

11.6x


Total Market Cap: S$13.9bTotal Earnings: S$1.2bTotal Revenue: S$5.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Singaporean Healthcare Sector Price to Earnings3Y Average 19.9x202320242025
Current Industry PE
  • Investors are optimistic on the Singaporean Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 25.2x which is higher than its 3-year average PE of 19.9x.
  • The industry is trading close to its 3-year average PS ratio of 2.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 34% per year over the last three years,
  • Revenues have also declined 17% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Trends

Which industries have driven the changes within the Singaporean Healthcare sector?

SG Market0.25%
Healthcare1.26%
Pharma1.71%
Healthcare Services1.12%
Medical Equipment0.91%
Healthtech0%0
Biotech0%0
Life Sciences0%0
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 31.1x.
    • Analysts are expecting annual earnings growth of 12.0%, which is higher than its past year's earnings decline of 26.0% per year.
  • Investors are most pessimistic about the Pharma industry, which is trading below its 3-year average of 16.9x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 12% over the next 5 years.
  • This is better than its past earnings decline of 26% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 6.7% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
H02 Haw ParS$11.411.3%
+S$33.2m		19.5%PE10.8x
A50 Thomson Medical GroupS$0.0492.1%
+S$26.4m		-10.9%PE83.9x
9G2 Singapore Institute of Advanced Medicine HoldingsS$0.04948.5%
+S$16.8m		n/aPS3.1x
1J5 Hyphens Pharma InternationalS$0.291.8%
+S$1.5m		1.8%PE8.6x
BFK Pharmesis InternationalS$0.587.3%
+S$1.3m		n/aPS2.4x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

FRQ

S$0.08

Singapore Paincare Holdings

7D

-17.5%

1Y

-50.0%

BSL

S$0.83

Raffles Medical Group

7D

-0.6%

1Y

-18.1%

1H3

S$0.003

Clearbridge Health

7D

-25.0%

1Y

-76.9%

H02

S$11.41

Haw Par

7D

1.3%

1Y

19.5%

Investors Holding Back On Haw Par Corporation Limited (SGX:H02)

Dec 19
Investors Holding Back On Haw Par Corporation Limited (SGX:H02)

9G2

S$0.049

Singapore Institute of Advanced Medicine Holdings

7D

48.5%

1Y

n/a

584

S$0.003

AJJ Medtech Holdings

7D

-25.0%

1Y

-50.0%

EHG

S$0.28

Econ Healthcare (Asia)

7D

-5.2%

1Y

37.5%

42C

S$0.022

iX Biopharma

7D

-8.3%

1Y

-48.8%

BFK

S$0.58

Pharmesis International

7D

7.3%

1Y

n/a

Is Pharmesis International (SGX:BFK) Using Too Much Debt?

Oct 10
Is Pharmesis International (SGX:BFK) Using Too Much Debt?

A50

S$0.049

Thomson Medical Group

7D

2.1%

1Y

-10.9%

1J5

S$0.29

Hyphens Pharma International

7D

1.8%

1Y

1.8%

5WA

S$0.027

OUE Healthcare

7D

-3.6%

1Y

-3.6%

1D4

S$0.044

Aoxin Q & M Dental Group

7D

-6.4%

1Y

-29.0%